EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems

Matthew Molinaro, David Skrodzki, Dipanjan Pan iD

WIREs Nanomedicine and Nanobiotechnology · 2024

DOI: 10.1002/wnan.1984 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2024. Verfasst von Matthew Molinaro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering Science and Mechanics, The Pennsylvania State University, University Park, Pennsylvania, USA. Hauptthemen laut MEDLINE: Nanomedicine, Chemoradiotherapy, Drug Delivery Systems, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 335 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Earth and Mineral Sciences, Pennsylvania State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy is an invaluable tool in the treatment of cancer. However, when used as a monotherapy, it fails to provide curative outcomes. Chemotherapy drugs are often included to boost the effects of radiation. Key classes of radiosensitizing drugs include platinum compounds, anthracyclines, antimetabolites, taxanes, topoisomerase inhibitors, alkylating agents, and DNA damage repair inhibitors. Chemoradiotherapy suffers from not only systemic toxicities from chemotherapy drugs but also synergistic radiation toxicity as well. It is critical to deliver radiosensitizing molecules to tumor cells while avoiding adjacent healthy tissues. Currently, nanomedicine provides an avenue for tumor specific delivery of radiosensitizers. Nanoscale delivery vehicles can be synthesized from lipids, polymers, or inorganic materials. Additionally, nanomedicine encompasses stimuli responsive particles including prodrug formulation for tumor specific activation. Clinically, nanomedicine and radiotherapy are intertwined with approved formulation including DOXIL and Abraxane. Though many challenges remain, the ongoing progress evidences a promising future for both nanomedicine and chemoradiotherapy. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Therapeutic Approaches and Drug Discovery > Nanomedicine for Cardiovascular Disease Therapeutic Approaches and Drug Discovery > Emerging Technologies

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineChemoradiotherapyDrug Delivery SystemsNeoplasmsHumansAnimalsAntineoplastic AgentsRadiation-Sensitizing Agents

Stichwörter der Autor:innen

cancerdrug deliverynanomedicineradiotherapy

Substanzen

Antineoplastic AgentsRadiation-Sensitizing Agents

Autor:innen und Institutionen

  • Department of Engineering Science and Mechanics, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Department of Materials Science and Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Department of Nuclear Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Center for Infectious Disease Dynamics, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Department of Biomedical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Huck Institutes of the Life Sciences, University Park, Pennsylvania, USA.

ORCID-Profile: Dipanjan Pan

Förderung

  • College of Earth and Mineral Sciences, Pennsylvania State University

Zitieren

APA

Molinaro, M., Skrodzki, D., & Pan, D. (2024). Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1984

Vancouver

Molinaro M, Skrodzki D, Pan D. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems. WIREs Nanomedicine and Nanobiotechnology. 2024. doi:10.1002/wnan.1984

BibTeX
@article{Molinaro2024,
  author = {Molinaro, Matthew and Skrodzki, David and Pan, Dipanjan},
  title = {Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems},
  journal = {WIREs Nanomedicine and Nanobiotechnology},
  year = {2024},
  doi = {10.1002/wnan.1984}
}
Kostenlos starten →